Cargando…
Biochemical and Structural Analysis of Inhibitors Targeting the ADC-7 Cephalosporinase of Acinetobacter baumannii
[Image: see text] β-Lactam resistance in Acinetobacter baumannii presents one of the greatest challenges to contemporary antimicrobial chemotherapy. Much of this resistance to cephalosporins derives from the expression of the class C β-lactamase enzymes, known as Acinetobacter-derived cephalosporina...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American
Chemical Society
2014
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4263437/ https://www.ncbi.nlm.nih.gov/pubmed/25380506 http://dx.doi.org/10.1021/bi500887n |
_version_ | 1782348569549733888 |
---|---|
author | Powers, Rachel A. Swanson, Hollister C. Taracila, Magdalena A. Florek, Nicholas W. Romagnoli, Chiara Caselli, Emilia Prati, Fabio Bonomo, Robert A. Wallar, Bradley J. |
author_facet | Powers, Rachel A. Swanson, Hollister C. Taracila, Magdalena A. Florek, Nicholas W. Romagnoli, Chiara Caselli, Emilia Prati, Fabio Bonomo, Robert A. Wallar, Bradley J. |
author_sort | Powers, Rachel A. |
collection | PubMed |
description | [Image: see text] β-Lactam resistance in Acinetobacter baumannii presents one of the greatest challenges to contemporary antimicrobial chemotherapy. Much of this resistance to cephalosporins derives from the expression of the class C β-lactamase enzymes, known as Acinetobacter-derived cephalosporinases (ADCs). Currently, β-lactamase inhibitors are structurally similar to β-lactam substrates and are not effective inactivators of this class C cephalosporinase. Herein, two boronic acid transition state inhibitors (BATSIs S02030 and SM23) that are chemically distinct from β-lactams were designed and tested for inhibition of ADC enzymes. BATSIs SM23 and S02030 bind with high affinity to ADC-7, a chromosomal cephalosporinase from Acinetobacter baumannii (K(i) = 21.1 ± 1.9 nM and 44.5 ± 2.2 nM, respectively). The X-ray crystal structures of ADC-7 were determined in both the apo form (1.73 Å resolution) and in complex with S02030 (2.0 Å resolution). In the complex, S02030 makes several canonical interactions: the O1 oxygen of S02030 is bound in the oxyanion hole, and the R1 amide group makes key interactions with conserved residues Asn152 and Gln120. In addition, the carboxylate group of the inhibitor is meant to mimic the C(3)/C(4) carboxylate found in β-lactams. The C(3)/C(4) carboxylate recognition site in class C enzymes is comprised of Asn346 and Arg349 (AmpC numbering), and these residues are conserved in ADC-7. Interestingly, in the ADC-7/S02030 complex, the inhibitor carboxylate group is observed to interact with Arg340, a residue that distinguishes ADC-7 from the related class C enzyme AmpC. A thermodynamic analysis suggests that ΔH driven compounds may be optimized to generate new lead agents. The ADC-7/BATSI complex provides insight into recognition of non-β-lactam inhibitors by ADC enzymes and offers a starting point for the structure-based optimization of this class of novel β-lactamase inhibitors against a key resistance target. |
format | Online Article Text |
id | pubmed-4263437 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | American
Chemical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-42634372015-11-07 Biochemical and Structural Analysis of Inhibitors Targeting the ADC-7 Cephalosporinase of Acinetobacter baumannii Powers, Rachel A. Swanson, Hollister C. Taracila, Magdalena A. Florek, Nicholas W. Romagnoli, Chiara Caselli, Emilia Prati, Fabio Bonomo, Robert A. Wallar, Bradley J. Biochemistry [Image: see text] β-Lactam resistance in Acinetobacter baumannii presents one of the greatest challenges to contemporary antimicrobial chemotherapy. Much of this resistance to cephalosporins derives from the expression of the class C β-lactamase enzymes, known as Acinetobacter-derived cephalosporinases (ADCs). Currently, β-lactamase inhibitors are structurally similar to β-lactam substrates and are not effective inactivators of this class C cephalosporinase. Herein, two boronic acid transition state inhibitors (BATSIs S02030 and SM23) that are chemically distinct from β-lactams were designed and tested for inhibition of ADC enzymes. BATSIs SM23 and S02030 bind with high affinity to ADC-7, a chromosomal cephalosporinase from Acinetobacter baumannii (K(i) = 21.1 ± 1.9 nM and 44.5 ± 2.2 nM, respectively). The X-ray crystal structures of ADC-7 were determined in both the apo form (1.73 Å resolution) and in complex with S02030 (2.0 Å resolution). In the complex, S02030 makes several canonical interactions: the O1 oxygen of S02030 is bound in the oxyanion hole, and the R1 amide group makes key interactions with conserved residues Asn152 and Gln120. In addition, the carboxylate group of the inhibitor is meant to mimic the C(3)/C(4) carboxylate found in β-lactams. The C(3)/C(4) carboxylate recognition site in class C enzymes is comprised of Asn346 and Arg349 (AmpC numbering), and these residues are conserved in ADC-7. Interestingly, in the ADC-7/S02030 complex, the inhibitor carboxylate group is observed to interact with Arg340, a residue that distinguishes ADC-7 from the related class C enzyme AmpC. A thermodynamic analysis suggests that ΔH driven compounds may be optimized to generate new lead agents. The ADC-7/BATSI complex provides insight into recognition of non-β-lactam inhibitors by ADC enzymes and offers a starting point for the structure-based optimization of this class of novel β-lactamase inhibitors against a key resistance target. American Chemical Society 2014-11-07 2014-12-09 /pmc/articles/PMC4263437/ /pubmed/25380506 http://dx.doi.org/10.1021/bi500887n Text en Copyright © 2014 American Chemical Society This is an open access article published under an ACS AuthorChoice License (http://pubs.acs.org/page/policy/authorchoice_termsofuse.html) , which permits copying and redistribution of the article or any adaptations for non-commercial purposes. |
spellingShingle | Powers, Rachel A. Swanson, Hollister C. Taracila, Magdalena A. Florek, Nicholas W. Romagnoli, Chiara Caselli, Emilia Prati, Fabio Bonomo, Robert A. Wallar, Bradley J. Biochemical and Structural Analysis of Inhibitors Targeting the ADC-7 Cephalosporinase of Acinetobacter baumannii |
title | Biochemical and Structural Analysis of Inhibitors Targeting the ADC-7 Cephalosporinase of Acinetobacter baumannii |
title_full | Biochemical and Structural Analysis of Inhibitors Targeting the ADC-7 Cephalosporinase of Acinetobacter baumannii |
title_fullStr | Biochemical and Structural Analysis of Inhibitors Targeting the ADC-7 Cephalosporinase of Acinetobacter baumannii |
title_full_unstemmed | Biochemical and Structural Analysis of Inhibitors Targeting the ADC-7 Cephalosporinase of Acinetobacter baumannii |
title_short | Biochemical and Structural Analysis of Inhibitors Targeting the ADC-7 Cephalosporinase of Acinetobacter baumannii |
title_sort | biochemical and structural analysis of inhibitors targeting the adc-7 cephalosporinase of acinetobacter baumannii |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4263437/ https://www.ncbi.nlm.nih.gov/pubmed/25380506 http://dx.doi.org/10.1021/bi500887n |
work_keys_str_mv | AT powersrachela biochemicalandstructuralanalysisofinhibitorstargetingtheadc7cephalosporinaseofacinetobacterbaumannii AT swansonhollisterc biochemicalandstructuralanalysisofinhibitorstargetingtheadc7cephalosporinaseofacinetobacterbaumannii AT taracilamagdalenaa biochemicalandstructuralanalysisofinhibitorstargetingtheadc7cephalosporinaseofacinetobacterbaumannii AT floreknicholasw biochemicalandstructuralanalysisofinhibitorstargetingtheadc7cephalosporinaseofacinetobacterbaumannii AT romagnolichiara biochemicalandstructuralanalysisofinhibitorstargetingtheadc7cephalosporinaseofacinetobacterbaumannii AT caselliemilia biochemicalandstructuralanalysisofinhibitorstargetingtheadc7cephalosporinaseofacinetobacterbaumannii AT pratifabio biochemicalandstructuralanalysisofinhibitorstargetingtheadc7cephalosporinaseofacinetobacterbaumannii AT bonomoroberta biochemicalandstructuralanalysisofinhibitorstargetingtheadc7cephalosporinaseofacinetobacterbaumannii AT wallarbradleyj biochemicalandstructuralanalysisofinhibitorstargetingtheadc7cephalosporinaseofacinetobacterbaumannii |